🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 556099109
- Market Cap
- Mid Cap
- IPO
- 10/9/2013 · $16.00/share
Business: MacroGenics, Inc. is a biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. MacroGenics creates both differentiated molecules that are directed to novel cancer targets, as well as bio-betters, which are drugs designed to improve upon marketed medicines.
Company Contact
- CEO
- Scott Koenig
- CFO
- James Karrels
- Headquarters
- 9704 Medical Center Drive, Rockville, MD 20850
- Phone
- 301-251-5172
- Investor Relations
- Anna Krassowska · 301-251-5172 · info@macrogenics.com